Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

NCT04747054 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: Pembrolizumab
RADIATION: Loco-regional radiotherapy
DRUG: Chemotherapy

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]